News

GeneDx is expanding product lines, improving margins, and increasing insurance coverage, with the recent acquisition. Read ...
On Tuesday, the Labor Department reported that the Consumer Price Index for April rose by only 0.2 percent last month, ...
Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine and patient care, has announced the presentation of six posters, including one oral ...
We’re winding down earnings season, and the old Wall Street adage that “earnings drive stock prices” continues to prove true.
We recently published a list of 11 Best Performing Healthcare Stocks to Buy Now. In this article, we are going to take a look ...
Despite a turbulent 2025, Ark Invest CEO Cathie Wood is currently sitting on a big win with her investment in Tempus AI ...
If the current pace of exits persists, it would take 30 years for every U.S. company on The Crunchbase Unicorn Board to go ...
Tempus AI is gaining traction and on track for profits this year; high short interest and rising institutional activity point ...
CompanyOverview|NASDAQ:TEM] Tempus AI (NASDAQ: TEM) is an interesting AI story that operates a platform and library for ...
The tech industry has been so excited about generative AI that everyone seems to miss a fundamental point: it’s not at all ...
Tempus AI shares rose after a Q1 beat, as an analyst highlighted its AI-driven growth, expanding pharma deals, and $1B+ ...